Hematology
Volume 28, 2023 - Issue 1
Open access
4,455
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma
Maral DerSarkissiana Analysis Group, Boston, MA, USACorrespondence[email protected]
View further author information
, View further author information
Holly Cranmerb Takeda Pharmaceuticals International AG, Zurich, SwitzerlandView further author information
, Jonathan Daborac Takeda Pharmaceuticals America, Inc., Lexington, MA, USAView further author information
, Iryna Bocharovaa Analysis Group, Boston, MA, USAView further author information
, Dasha Cherepanovd Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USAView further author information
, Mu Chenga Analysis Group, Boston, MA, USAView further author information
, Rachel H. Bhaka Analysis Group, Boston, MA, USAView further author information
& Mei Sheng Duha Analysis Group, Boston, MA, USAView further author information
show all
Article: 2156731
|
Received 24 Aug 2022, Accepted 04 Dec 2022, Published online: 06 Jan 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.